Some new specialty treatments for patients with rare and chronic diseases are nothing short of transformational, allowing many to live longer and healthier lives. However, these new treatments are often expensive, creating challenges for health insurance
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/03/23/collaboration-with-chronic-disease-groups-optimizes-outcomes-for-payers-and-patients/
Posted
Mar 23 2016, 10:30 AM
by
Health Affairs Blog
Filed under: Featured, Payment Policy, Insurance and Coverage, Organization and Delivery, Costs and Spending, Health Professionals, chronic disease, patient uses of evidence, Immune Deficiency Foundation, Health Care Service Corporation, immunodeficiency diseases